Australia markets closed

Cipher Pharmaceuticals Inc (PHE.SG)

Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
5.800.00 (0.00%)
At close: 07:39PM CEST
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
22,680
20,383
26,636
7,758
4,549
-
Depreciation & amortisation
1,173
1,227
989
701
1,205
-
Deferred income taxes
-4,677
-2,737
-14,310
-114
-1,413
-
Stock-based compensation
970
1,190
403
139
122
-
Change in working capital
-6,242
-3,276
-3,034
4,678
1,723
-
Accounts receivable
-2,946
1,714
-144
2,562
-342
-
Inventory
-385
-830
-502
-758
151
-
Accounts payable
2,014
532
-1,448
-1,231
283
-
Other working capital
13,618
15,855
10,644
13,814
10,931
-
Other non-cash items
-7
-10
6
92
363
-
Net cash provided by operating activities
13,768
15,999
10,725
13,814
11,691
-
Cash flows from investing activities
Investments in property, plant and equipment
-
-144
-81
-
-760
-1,311
Acquisitions, net
-
-
-
-
0
-374
Net cash used for investing activities
-150
-144
-81
0
-760
-
Cash flows from financing activities
Debt repayment
-
-
-58
-828
-7,929
-10,000
Common stock issued
-
-
-
-
38
70
Common stock repurchased
-5,663
-5,559
-1,988
-1,717
-78
-
Dividends paid
-
-
-
-
0
0
Net cash used provided by (used for) financing activities
-5,311
-5,244
-1,912
-2,470
-8,132
-
Net change in cash
8,307
10,611
8,732
11,344
2,798
-
Cash at beginning of period
33,427
28,836
20,548
9,142
6,346
-
Cash at end of period
41,734
39,825
28,836
20,548
9,142
-
Free cash flow
Operating cash flow
13,768
15,999
10,725
13,814
11,691
-
Capital expenditure
-
-144
-81
-
-760
-1,311
Free cash flow
13,618
15,855
10,644
13,814
10,931
-